Comparison of Contrast Agents During CT Angiography

计划入组 513 人 · 首次发布于 2012 年 2 月 17 日

Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide

计划入组 420 人 · 首次发布于 2009 年 1 月 15 日

Comparison of Contrast Agent Administration Protocols

计划入组 67 人 · 首次发布于 2020 年 3 月 9 日

High Relaxivity Contrast Agent

nanoparticle DECT contrast agent

microbubble-based ultrasound contrast agent

CMC Contrast AB

Sweden

Dark Canyon Laboratories, LLC

United States

HEC Pharm USA Inc.

United States

New Dark Borosilicate Contrast Agent Shows Promise for Enhanced CT Imaging of Bowel Pathologies

FDA Approves First Iron-Based Contrast Agent for Brain MRI Imaging

Bayer Submits Low-Dose MRI Contrast Agent Gadoquatrane for Global Regulatory Approval